Chapter 10: Recombinant DNA Technology and Applications
Loading audio…
ⓘ This audio and summary are simplified educational interpretations and are not a substitute for the original text.
Recombinant DNA Technology and Applications explains methods for constructing restriction maps to locate specific sites on DNA and strategies for directional cloning using restriction enzymes to ensure correct insert orientation. The text elaborates on the creation and screening of genomic and cDNA libraries, utilizing techniques like antibody detection, DNA probes, and complementation to isolate specific genes of interest. Significant attention is given to the Polymerase Chain Reaction (PCR) and its variants, including Reverse Transcription PCR (RT-PCR) for analyzing RNA expression, Real-time quantitative PCR for measuring mRNA abundance, and site-specific mutagenesis for engineering precise DNA alterations. Analytical techniques such as Southern blotting for DNA and Northern blotting for RNA are described for characterizing gene structure and expression levels. The chapter also introduces the yeast two-hybrid system (interaction trap assay) for detecting protein-protein interactions within the cell. A major section focuses on DNA polymorphisms, including Single Nucleotide Polymorphisms (SNPs), Short Tandem Repeats (STRs or microsatellites), and Variable Number Tandem Repeats (VNTRs), explaining their utility in genetic mapping, disease diagnosis, and forensic DNA typing. Practical applications in human health are covered through DNA molecular testing methods like Allele-Specific Oligonucleotide (ASO) hybridization, Restriction Fragment Length Polymorphism (RFLP) analysis, and DNA microarrays for screening complex diseases like breast cancer (BRCA genes). The summary further examines the principles of DNA fingerprinting for paternity testing and criminal investigations, establishing identity through exclusion or inclusion based on allele frequencies. Finally, the text addresses biotechnology applications, including somatic and germ-line gene therapy for treating genetic disorders, the commercial production of pharmaceutical proteins like insulin, and agricultural genetic engineering using Agrobacterium tumefaciens Ti plasmids or gene guns to create transgenic plants with traits like herbicide resistance or edible vaccines.